Initiation of Antiretroviral Therapy Before Pregnancy Reduces the Risk of Infection-related Hospitalization in Human Immunodeficiency Virus–exposed Uninfected Infants Born in a High-income Country. (12th September 2018)

• Record Type: Journal Article
• Authors: Goetghebuer, Tessa; Smolen, Kinga K; Adler, Catherine; Das, Jishnu; McBride, Trevor; Smits, Gaby; Lecomte, Sandra; Haelterman, Edwige; Barlow, Patricia; Piedra, Pedro A; van der Klis, Fiona; Kollmann, Tobias R; Lauffenburger, Douglas A; Alter, Galit; Levy, Jack; Marchant, Arnaud
• Is Part Of: Clinical infectious diseases. Volume 68:Number 7(2019)
• Page Start: 1193
• Page End: 1203
• Publication Date: 2018-09-12
• Subjects: maternal HIV -- anti-retroviral therapy -- maternal antibodies -- immune activation -- infant infections; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciy673
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Background: Epidemiological studies conducted in low- and high-income countries showed that infants exposed to maternal human immunodeficiency virus (HIV) have a high risk of severe infections. Immune alterations during fetal life have been proposed as a possible mechanism. Methods: This prospective study assessed the relative risk of hospitalization for infection in HIV-exposed uninfected (HEU) infants as compared to HIV-unexposed (HU) infants born in a high-income country (HIC). Markers of monocyte activation and levels of pathogen-specific antibodies were measured at birth to identify correlates of infant susceptibility. Results: There were 27 of 132 HEU infants and 14 of 123 HU infants hospitalized for infection during the first year of life (adjusted hazard ratio [aHR] 2.33, 95% confidence interval [CI] 1.10–4.97). Most of this increased risk was associated with the time of initiation of maternal antiretroviral therapy (ART). As compared to HU infants, the risk of hospitalization for infection of HEU infants was 4-fold higher when mothers initiated ART during pregnancy (aHR 3.84, 95% CI 1.69–8.71) and was not significantly increased when ART was initiated before pregnancy (aHR 1.42, 95% CI 0.58–3.48). The activation of newborn monocytes and the reduced transfer of maternal antibodies were most intense following ART initiation during pregnancy, and predicted the risk of infant hospitalization. Conclusions: These observations indicate that initiation of maternal ART before pregnancy reduces the susceptibility of HEU infants born in a HIC to severe infections, and that this effect could be related to the prevention of immune alterations during fetal life. Abstract : Human immunodeficiency virus (HIV)-exposed, uninfected infants born in Belgium have a 2-fold higher risk of hospitalization for infection than HIV-unexposed infants. Infectious risks were reduced by anti-retroviral therapy before pregnancy and were predicted by immune alterations induced during fetal life.